TerminatedPhase 1Phase 2

A Study of Fruquintinib in Combination With Tislelizumab in Advanced Solid Tumors

NCT04577963

What is this trial?

Generating plain-language summary...

Generating eligibility summary...

Summarizing study design...

Primary location

Mayo Clinic Arizona

Phoenix, Arizona, United States

+15 additional locations

Save this trial

Mayo Clinic ArizonaPhoenix, Arizona, United States
Highlands OncologySpringdale, Arkansas, United States
Beverly Hills Cancer CenterBeverly Hills, California, United States
University of ColoradoAurora, Colorado, United States
Florida Cancer Specialists - FCS SouthPort Charlotte, Florida, United States
Florida Cancer Center NorthSt. Petersburg, Florida, United States
Florida Cancer Specialists PanhandleTallahassee, Florida, United States
Florida Cancer Specialists - East (FCS East)West Palm Beach, Florida, United States
HOC AON Baton Rouge / Sarah CannonBaton Rouge, Louisiana, United States
Messino Cancer CenterAsheville, North Carolina, United States
Oklahoma University Stephenson Cancer CenterOklahoma City, Oklahoma, United States
Women and Infants Hospital of Rhode IslandProvidence, Rhode Island, United States
Tennessee Oncology-ChattanoogaChattanooga, Tennessee, United States
Tennesse OncologyNashville, Tennessee, United States
Vanderbilt Ingram Cancer CenterNashville, Tennessee, United States
The University of Texas MD Anderson Cancer CenterHouston, Texas, United States